European Spine Journal

, Volume 24, Issue 8, pp 1768–1777 | Cite as

Safety of percutaneous vertebroplasty for the treatment of metastatic spinal tumors in patients with posterior wall defects

  • Hongpu Sun
  • Zuozhang YangEmail author
  • Yongqing XuEmail author
  • Xuefeng Liu
  • Ya Zhang
  • Yanjin Chen
  • Da Xu
  • Yihao Yang
  • Dongqi Li
  • Junfeng Xia
Original Article



To assess the clinical effect of percutaneous vertebroplasty (PVP) in the treatment of metastatic spinal tumors in patients with posterior wall defect.


The treated vertebrae bodies were divided into four groups: group A, non-posterior vertebral wall defect; group B, posterior vertebral wall with cribriform defects; group C, posterior vertebral wall with local fragmentation defects; group D, posterior vertebral wall with severe defects. The injected volume of bone cement, visual analogue scale (VAS) score, Karnofsky Performance Scale (KPS), cement leakage and survival were analyzed.


The injected volume of bone cement for group A was significantly higher than posterior wall defect group (including group B, C, and D). No significant differences about the injected volume of bone cement among the posterior wall defect groups. The incidence of bone cement leakage for group A was not significantly different as compared to posterior vertebral wall defect group. However, there were significant differences with respect to the incidence of bone cement leakage among the posterior wall defect groups. In four groups the postoperative VAS pain scores and KPS were statistical different as comparison to the preoperative values. No statistical difference with respect to the VAS pain scores and KPS was observed at any time point between the non-posterior wall defect group and posterior wall defect group.


PVP can be an effective treatment for metastatic spinal tumors in patients with posterior wall deficiency; however, care should be taken to control the distribution of the bone cement due to the relatively high risk of cement leakage.


Spinal metastasis Percutaneous vertebroplasty Posterior wall defect Metastatic Tumor Cement 



This research was supported in part by Grants (no. 81260322/H1606, no. 81372322/H1606 and no. 81460440/H1606) from the National Natural Science Foundation of China, a Grant (no. 2012FB163) from the Natural Science Foundation of Yunnan Province, a Grant (no. 2011FB201) from the Joint Special Funds for the Department of Science and Technology of Yunnan Province-Kunming Medical University, and a Grant (no. D-201242) from the specialty fund of high-level talents medical personnel training of Yunnan province.

Conflict of interest

The authors have no conflict of interest to declare.


  1. 1.
    Shimazaki J, Higa T, Akimoto S, Masai M, Isaka S (1992) Clinical course of bone metastasis from prostatic cancer following endocrine therapy: examination with bone x-ray. In: Prostate Cancer and Bone Metastasis. Springer, pp 269–275Google Scholar
  2. 2.
    Scutellari P, Antinolfi G, Galeotti R, Giganti M (2003) Metastatic bone disease. Strategies for imaging. Minerva Med 94:77–90PubMedGoogle Scholar
  3. 3.
    Desforges JF, Byrne TN (1992) Spinal cord compression from epidural metastases. N Engl J Med 327:614–619CrossRefGoogle Scholar
  4. 4.
    Gerszten PC, Welch WC (2000) Current surgical management of metastatic spinal disease. Oncology (Williston Park, NY) 14(7):1013–1024 (discussion 1024, 1029–1030)Google Scholar
  5. 5.
    Gilbert RW, Kim JH, Posner JB (1978) Epidural spinal cord compression from metastatic tumor: diagnosis and treatment. Ann Neurol 3:40–51PubMedCrossRefGoogle Scholar
  6. 6.
    Gokaslan ZL (1996) Spine surgery for cancer. Curr Opin Oncol 8:178–181PubMedCrossRefGoogle Scholar
  7. 7.
    Nazzaro J (1999) Metastatic spinal lesions. Spine Surgery: techniques, complication avoidance, and management, vol 1. New York, Churchill Livingstone, pp 679–695Google Scholar
  8. 8.
    Gokaslan ZL, York JE, Walsh GL, McCutcheon IE, Lang FF, Putnam JB Jr, Wildrick DM, Swisher SG, Abi-Said D, Sawaya R (1998) Transthoracic vertebrectomy for metastatic spinal tumors. J Neurosurg 89:599–609PubMedCrossRefGoogle Scholar
  9. 9.
    Jackson RJ, Gokaslan ZL, Arvinloh S-C (2001) Metastatic renal cell carcinoma of the spine: surgical treatment and results. J Neurosurg Spine 94:18–24CrossRefGoogle Scholar
  10. 10.
    Weill A, Chiras J, Simon JM, Rose M, Sola-Martinez T, Enkaoua E (1996) Spinal metastases: indications for and results of percutaneous injection of acrylic surgical cement. Radiology 199:241–247PubMedCrossRefGoogle Scholar
  11. 11.
    Galibert P, Deramond H, Rosat P, Le Gars D (1987) Preliminary note on the treatment of vertebral angioma by percutaneous acrylic vertebroplasty. Neurochirurgie 33(2):166–168PubMedGoogle Scholar
  12. 12.
    van der Linden E, Kroft LJ, Dijkstra P (2007) Treatment of vertebral tumor with posterior wall defect using image-guided radiofrequency ablation combined with vertebroplasty: preliminary results in 12 patients. J Vasc Interv Radiol 18:741–747PubMedCrossRefGoogle Scholar
  13. 13.
    Murphy KJ, Nwankwo IJ, Gailloud P (2007) Percutaneous vertebroplasty in the treatment of blastic vertebral column metastasis from breast cancer. J Vasc Interv Radiol 18:321–323PubMedCrossRefGoogle Scholar
  14. 14.
    Yang Z, Tan J, Xu Y, Sun H, Xie L, Zhao R, Wang J, Jiang H (2012) Treatment of MM-associated spinal fracture with percutaneous vertebroplasty (PVP) and chemotherapy. Eur Spine J 21:912–919PubMedCentralPubMedCrossRefGoogle Scholar
  15. 15.
    Yao KC, Boriani S, Gokaslan ZL, Sundaresan N (2003) En bloc spondylectomy for spinal metastases: a review of techniques. Neurosurg Focus 15:1–6CrossRefGoogle Scholar
  16. 16.
    Burton AW, Reddy SK, Shah HN, Tremont-Lukats I, Mendel E (2005) Percutaneous vertebroplasty—a technique to treat refractory spinal pain in the setting of advanced metastatic cancer: a case series. J Pain Symptom Manage 30:87–95PubMedCrossRefGoogle Scholar
  17. 17.
    Chew C, Craig L, Edwards R, Moss J, O’Dwyer P (2011) Safety and efficacy of percutaneous vertebroplasty in malignancy: a systematic review. Clin Radiol 66:63–72PubMedCrossRefGoogle Scholar
  18. 18.
    Murphy K, Deramond H (2000) Percutaneous vertebroplasty in benign and malignant disease. Neuroimaging Clin N Am 10:535–545PubMedGoogle Scholar
  19. 19.
    Heini P, Wälchli B, Berlemann U (2000) Percutaneous transpedicular vertebroplasty with PMMA: operative technique and early results. Eur Spine J 9:445–450PubMedCentralPubMedCrossRefGoogle Scholar
  20. 20.
    Lo SS, Sahgal A, Wang JZ, Mayr NA, Sloan A, Mendel E, Chang EL (2010) Stereotactic body radiation therapy for spinal metastases. Discov Med 9:289–296PubMedGoogle Scholar
  21. 21.
    Sheehan JP, Jagannathan J (2008) Review of spinal radiosurgery: a minimally invasive approach for the treatment of spinal and paraspinal metastases. Neurosurg Focus 25(2):E18PubMedCrossRefGoogle Scholar
  22. 22.
    Algra PR, Heimans JJ, Valk J, Nauta J, Lachniet M, Van Kooten B (1992) Do metastases in vertebrae begin in the body or the pedicles? Imaging study in 45 patients. Am J Roentgenol 158:1275–1279CrossRefGoogle Scholar
  23. 23.
    Martin J, Jean B, Sugiu K, San Millan Ruiz D, Piotin M, Murphy K, Rüfenacht B, Muster M, Rüfenacht D (1999) Vertebroplasty: clinical experience and follow-up results. Bone 25:11S–15SPubMedCrossRefGoogle Scholar
  24. 24.
    Mathis JM, Barr JD, Belkoff SM, Barr MS, Jensen ME, Deramond H (2001) Percutaneous vertebroplasty: a developing standard of care for vertebral compression fractures. Am J Neuroradiol 22:373–381PubMedGoogle Scholar
  25. 25.
    Cotten A, Dewatre F, Cortet B, Assaker R, Leblond D, Duquesnoy B, Chastanet P, Clarisse J (1996) Percutaneous vertebroplasty for osteolytic metastases and myeloma: effects of the percentage of lesion filling and the leakage of methyl methacrylate at clinical follow-up. Radiology 200:525–530PubMedCrossRefGoogle Scholar
  26. 26.
    Yang Z, Yang D, Xie L, Sun Y, Huang Y, Sun H, Liu P, Wu Z (2009) Treatment of metastatic spinal tumors by percutaneous vertebroplasty versus percutaneous vertebroplasty combined with interstitial implantation of 125I seeds. Acta Radiol 50:1142–1148PubMedCrossRefGoogle Scholar
  27. 27.
    McDonald R, Trout A, Gray L, Dispenzieri A, Thielen K, Kallmes D (2008) Vertebroplasty in multiple myeloma: outcomes in a large patient series. Am J Neuroradiol 29:642–648PubMedCrossRefGoogle Scholar
  28. 28.
    Tokuhashi Y, Ajiro Y, Umezawa N (2009) Outcome of treatment for spinal metastases using scoring system for preoperative evaluation of prognosis. Spine 34:69–73PubMedCrossRefGoogle Scholar
  29. 29.
    van der Linden YM, Dijkstra SP, Vonk EJ, Marijnen CA, Leer JWH (2005) Prediction of survival in patients with metastases in the spinal column. Cancer 103:320–328PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2015

Authors and Affiliations

  • Hongpu Sun
    • 1
  • Zuozhang Yang
    • 1
    Email author
  • Yongqing Xu
    • 1
    Email author
  • Xuefeng Liu
    • 1
  • Ya Zhang
    • 1
  • Yanjin Chen
    • 1
  • Da Xu
    • 1
  • Yihao Yang
    • 1
  • Dongqi Li
    • 1
  • Junfeng Xia
    • 1
  1. 1.Department of OrthopaedicsThe Third Affiliated Hospital of Kunming Medical University, General Hospital of Chengdu Military CommandKunmingPeople’s Republic of China

Personalised recommendations